Q1: Disease Status at Infusion

!Disease Status At Infusion
The disease status at infusion (prior the start of the preparative regimen) section will enable only for the commercially available product Tecelra® (afamitresgene autoleucel)

!Disease Status At Infusion
The disease status at infusion (prior the start of the preparative regimen) section can only be completed at the “at infusion” timepoint. This question will be skipped for all subsequent reporting periods.

Question 1: Disease status

A metastatic solid tumor is a cancer that has spread from its original location to another part of the body.

Locally advanced refers to a cancerous tumor that has grown significantly within its original site in the body but has not yet become metastatic.

An unresectable solid tumor is a malignant solid tumor that cannot be removed by surgery.

Indicate if the tumor treated with Tecelra® (afamitresgene autoleucel) was either Metastatic or Locally advanced / unresectable prior to the start of the preparative regimen. This will be documented in a note by the physician.

Section Updates:

Question Number	Date of Change	Add/Remove/Modify	Description	Reasoning (If applicable)
.	.		.	.

Copyright © 2004-2024 The Medical College of Wisconsin, Inc. and NMDP. All Rights Reserved.
CIBMTR® (Center for International Blood and Marrow Transplant Research) is a research collaboration between the Medical College of Wisconsin and NMDP.